In summary, we have revealed the anti-parthanaos and anti-oxidative stress effects of crocetin and demonstrated its protecting effect against ischemic stroke in vitro and in vivo, opening a new venue of anti-stroke strategy via inhibiting NOX2 activity and/or preserving mitochondrial HK-I. This evidence concerns the gene HK1 and stroke disorder.